Indeed, the oncogenic role of PIK3R2 has been demonstrated in breast and colon cancer, in which over-expression of PIK3R2 with concomitant AKT activation correlated with tumor progression in vivo [32]. This evidence concerns the gene PIK3R2 and malignant colon neoplasm.